Leverage our rich experience in product development activities for the pharm industry

  • The business management team has been engaged in pharmaceutical marketing in China for almost two decades, already accumulated rich experience. With KOL system and close cooperation with each medical association, your products will rapidly cover the target hospitals.
  • Our in-house promotion staff is distributed in the major cities in Chinese with 27 local offices; self-operation network covering provinces and cities including Jiangsu, Zhejiang, Shanghai, Guangdong, Beijing, Sichuan, Chongqing, Hubei, Anhui, Yunnan, Shaanxi, Xinjiang, Henan, Shanxi, Hebei, Guangxi, Fujian, Shandong, Heilongjiang, Liaoning, Jilin and Inner Mongolia; more than 250 in-house full-time sales representatives, 80% with pharmaceutical and medical academic background; covering 1500major hospitals (>300beds), and 2000 community hospitals (<300beds).
  • Conduct academic promotion at national academic seminars and symposiums, and spread across every province and city via the KOL network.
  • Collaborate with hospitals and associations/societies to carry out series of clinical observational studies, in purposes of expanding the product application to new departments or inspecting the product safety, as reference for practitioners in other hospitals over China, and also providing data for your global database.
  • Rapid distribution capability to OTC market, high efficiency of salesperson training, and proving patients with medical education to maintain customer base. Currently cover 20,000+ drugstores of major pharmacy chain. Fast growing OTC sales team with 40+ full-time promoters.
Academic Meetings and events
Academic promotion with high efficiency, professionism and legal compliance
Multi distribution channels
Whole coverage of hospital and OTC channels
Healthcare communication
Meet clinical demands, grasp market dynamics
Patient education and support service
Maintain and expand customer base by drug-use education
Expand application territories, inspect drug safety